9 completed, 1 recruiting. 3 Not applicable, 2 Phase 3, 2 Phase 4, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Completed 3 |
| Phase 3 | 2 | Completed 2 |
| Phase 4 | 2 | Completed 1, Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Lallemand Pharma AG: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Prevention With Ismigen of RTIs in Kids Bacterial Lysates, Placebo - Respiratory Tract Infections (RTI), Healthy Children | Phase 4 | Recruiting | Lallemand Pharma AG | 224 | 2026-06-01 | 2026-07-08 |
| Prevention With Healsea in Adults Against Respiratory Infection Study Healsea Children nasal spray - Healthy Subjects (HS) | Not applicable | Completed | Lallemand Pharma AG | 198 | 2024-11-29 | 2025-07-22 |
| HEALSea Nasal Spray for Prevention of Infections in Children Healsea Children - Healthy Subjects | Phase 2 / Phase 3 | Completed | Lallemand Pharma AG | 139 | 2024-11-25 | 2025-07-22 |
| Survey of Incidence of Respiratory Tract Infections No intervention - Healthy Adults, Not Healthy Adults | Completed | Lallemand Pharma AG | 1736 | 2023-11-07 | 2025-08-11 | |
| BАbykids Spray In Common Cold Healsea Babykids, Placebo - Common Cold, Rhinitis Viral | Not applicable | Completed | Lallemand Pharma AG | 200 | 2023-02-13 | 2024-10-08 |
| Testing the Efficacy in Adults With Cold of HEalsea Rescue* Healsea Rescue*, Placebo - Common Cold | Not applicable | Completed | Lallemand Pharma AG | 200 | 2022-12-14 | 2024-10-08 |
| Impact of Symbiofilm On Nasal Microbiota Healsea® Chronic, hypertonic seawater-based nasal spray supplemented with natural Symbiofilm® extract - Rhinosinusitis Chronic, Microbiome | Completed | Lallemand Pharma AG | 12 | 2022-12-12 | 2024-11-08 | |
| Symbiofilm Trial in Allergic Kids (SYMBIOFILM-TAK) Healsea® Children, Conventional therapies for common cold - Common Cold, Allergy | Completed | Lallemand Pharma AG | 186 | 2022-02-14 | 2025-01-20 | |
| Efficacy Of Bacterial Lysate In Asthmatic Children ISMIGEN, PLACEBO - Allergic Asthma | Phase 3 | Completed | Lallemand Pharma AG | 150 | 2014-07-01 | 2015-09-07 |
| Advanced Immunological Approach in COPD Exacerbation Placebo, Ismigen - Chronic Obstructive Pulmonary Disease (COPD) | Phase 4 | Completed | Lallemand Pharma AG | 288 | 2009-09-01 | 2015-04-15 |
Respiratory Tract Infections (5) · Common Cold (3) · Hypersensitivity (1) · Pulmonary Disease, Chronic Obstructive (1) · Rhinosinusitis (1)
Broncho-Vaxom (3) · Bacterial Lysates (1) · Cold Temperature (1)
Bulgaria (4) · Poland (3) · Italy (2) · France (1)
Frederic Durmont, MD (1) · Giorgio Walter Canonica, Prof. MD (1) · Pr Guillaume de Bonnecaze, MD, PhD (1) · Sergio Bonini, Professor (1)
PMID 12517470, PMID 24415465, PMID 28492494, PMID 29575037, PMID 32077450, PMID 33472687
2025 (1)